Endocrine System Diseases
Information
- Disease name
- Endocrine System Diseases
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05691712 | Active, not recruiting | Phase 3 | A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes | February 5, 2023 | July 2024 |
| NCT05505994 | Active, not recruiting | Phase 3 | The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin | September 28, 2022 | September 2024 |
| NCT02710370 | Active, not recruiting | Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans | February 2016 | August 31, 2026 | |
| NCT05778071 | Active, not recruiting | Phase 3 | Evaluation of the Safety and Efficacy of Eneboparatide (AZP-3601) in Patients With Chronic Hypoparathyroidism | June 7, 2023 | June 2025 |
| NCT05276063 | Active, not recruiting | Phase 2/Phase 3 | A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) | July 1, 2022 | September 2026 |
| NCT05933616 | Active, not recruiting | N/A | Analysis of Volatile Organic Compounds in Patients With Type 1 Diabetes in Induced Hypoglycaemia With a Breath Analyser | April 1, 2023 | April 30, 2024 |
| NCT05260021 | Active, not recruiting | Phase 3 | A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both | April 13, 2022 | February 2025 |
| NCT05749770 | Active, not recruiting | Hormonal Contributors to COVID-19 Infection (COV-ENDO) | May 1, 2020 | June 30, 2024 | |
| NCT05171855 | Active, not recruiting | Phase 3 | A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency | December 16, 2021 | January 2025 |
| NCT05014204 | Active, not recruiting | N/A | Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II Diabetes | October 29, 2021 | October 2024 |
| NCT04009291 | Active, not recruiting | Phase 2 | A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism | August 27, 2019 | March 2025 |
| NCT05445284 | Active, not recruiting | N/A | Group Education Trial to Improve Transition for Parents of Adolescents With T1D | October 10, 2023 | March 2026 |
| NCT04701203 | Active, not recruiting | Phase 3 | A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Adults With Hypoparathyroidism | February 16, 2021 | January 2025 |
| NCT01892956 | Completed | Observational Study of Blood Glucose Levels and Gut Microbiota in Healthy Individuals | April 2013 | October 30, 2019 | |
| NCT01917760 | Completed | Pharmacokinetics Study of Gamma-aminobutyric Acid | July 2013 | December 2014 | |
| NCT01964430 | Completed | Phase 3 | Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) | March 28, 2014 | June 30, 2022 |
| NCT02020395 | Completed | Phase 1 | Effect of a Test Meal on Satiation Hormones in Obese and Normal Weight Adolescents | June 2009 | October 2013 |
| NCT02102737 | Completed | Phase 2 | Comparison of A New Technique of Measure of the Insulin Resistance By Scintigraphy With the Reference Technique | May 13, 2014 | March 2018 |
| NCT02129868 | Completed | N/A | Automated Closed-loop in Children and Adolescents With Type 1 Diabetes | April 2014 | April 2015 |
| NCT02523131 | Completed | N/A | Home Testing of Day and Night Closed Loop With Pump Suspend Feature | May 2016 | March 2018 |
| NCT02563847 | Completed | N/A | Effect of Amino Acids and Sugar Alcohols on Gastric Emptying and Release of Satiation Peptides in Humans | May 2014 | |
| NCT02644759 | Completed | Phase 1/Phase 2 | Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes Mellitus | February 2014 | May 2018 |
| NCT02781727 | Completed | Phase 3 | A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD) | December 13, 2016 | January 17, 2019 |
| NCT02782208 | Completed | N/A | Lipolytic Effects of GH in Hypopituitary Patients in Vivo | February 10, 2016 | December 22, 2016 |
| NCT02823249 | Completed | N/A | Effect of Amino Acids and Sugar Alcohols on Satiation Peptides and Activation of Specific Brain Regions | May 2014 | April 2015 |
| NCT02925299 | Completed | N/A | Day and Night Closed-loop in Young People With Type 1 Diabetes | May 12, 2017 | August 27, 2020 |
| NCT03037385 | Completed | Phase 1/Phase 2 | Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors | March 17, 2017 | March 21, 2024 |
| NCT03199638 | Completed | N/A | Exercise Snacks and Glutamine to Improve Glucose Control in Adolescents With Type 1 Diabetes | April 1, 2016 | June 30, 2017 |
| NCT03305016 | Completed | Phase 3 | A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency | November 13, 2017 | March 19, 2019 |
| NCT00163215 | Completed | Phase 3 | Growth Retardation In Children With Special Pathological Conditions Or Disease | January 2005 | October 2011 |
| NCT03342495 | Completed | N/A | Evaluating Innovations in Transition From Pediatric to Adult Care - The Transition Navigator Trial | February 6, 2018 | September 7, 2021 |
| NCT03344458 | Completed | Phase 3 | A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial | December 19, 2017 | February 21, 2023 |
| NCT03345004 | Completed | Phase 2 | Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes | December 20, 2017 | April 27, 2021 |
| NCT03486223 | Completed | Phase 2 | Soluble Epoxide Hydrolase Inhibition and Insulin Resistance | May 17, 2018 | November 18, 2021 |
| NCT03492242 | Completed | Immune CHeckpoint Inhibitors Monitoring of Adverse Drug ReAction | February 1, 2018 | September 30, 2018 | |
| NCT03503747 | Completed | Investigating Genetic Risk for Type 1 Diabetes | April 25, 2018 | August 31, 2021 | |
| NCT03535727 | Completed | Phase 1/Phase 2 | A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer | June 21, 2018 | October 3, 2022 |
| NCT03562897 | Completed | Phase 2 | Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer | October 25, 2018 | June 15, 2022 |
| NCT03627611 | Completed | Phase 2 | Identification of Non-responders to Levothyroxine Therapy | August 14, 2018 | June 22, 2020 |
| NCT03675360 | Completed | N/A | Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial | September 25, 2018 | June 21, 2021 |
| NCT03717298 | Completed | Phase 2 | Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma | October 30, 2018 | January 20, 2023 |
| NCT03725813 | Completed | N/A | Study Evaluating the Effect of Person-centred Care for Patients Admitted for Inpatient Care at an Internal Medicine Unit | November 9, 2015 | June 30, 2016 |
| NCT03328546 | Completed | Dietary Patterns and Health Outcomes (Cardiovascular, Metabolic, Endocrine, Neurological, Skeletal Muscular, Cancer) | January 1, 1989 | April 2018 | |
| NCT00672386 | Completed | Phase 2 | A Study of the Safety and Effectiveness of a R256918 in Patients With Type 2 Diabetes | December 2007 | September 2008 |
| NCT00947713 | Completed | Phase 1/Phase 2 | Comparison of Micro-dose Human Chorionic Gonadotropin (hCG) With Human Menopausal Gonadotropin (HMG) in Polycystic Ovary Syndrome | August 2009 | December 2010 |
| NCT01103245 | Completed | Phase 1 | Aldosterone and the Metabolic Syndrome | March 2010 | September 2013 |
| NCT01301456 | Completed | Phase 1 | Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult Females | March 2011 | April 2012 |
| NCT01318564 | Completed | Diabetic Treatment Adherence | March 2011 | August 2016 | |
| NCT01435603 | Completed | N/A | Intervening in Diabetes With Healthy Eating, Activity, and Linkages To Healthcare - The I-D-HEALTH Study | August 2011 | September 2016 |
| NCT01456572 | Completed | Phase 1 | Gastric and Intestinal Satiation in Obese and Normal Weight Healthy People | January 2007 | July 2011 |
| NCT01553344 | Completed | Serum Sclerostin Level & Treatment of Vitamin D Deficiency | March 2012 | November 2013 | |
| NCT01727973 | Completed | Phase 1/Phase 2 | Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy | October 2012 | November 2013 |
| NCT01778348 | Completed | Phase 2 | Closing the Loop in Children and Adolescents With Type 1 Diabetes in the Home Setting | December 2013 | May 2015 |
| NCT01873066 | Completed | N/A | Closing the Loop 24/7 in Adolescents With Type 1 Diabetes | August 28, 2014 | January 1, 2016 |
| NCT01875575 | Completed | N/A | Oral Glucose Stimulation in Normal-weight and Obese Volunteers | February 2013 | April 2013 |
| NCT04488432 | Completed | Endocrine, Bone And Metabolic Disorders In Adults After Allogeneic Stem-cell Transplant | November 27, 2019 | November 27, 2019 | |
| NCT04615273 | Completed | Phase 3 | A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency | December 3, 2020 | December 1, 2023 |
| NCT04768621 | Completed | N/A | Health Consequences of Wintering in the French Southern and Antarctic Territories | April 20, 2021 | June 19, 2021 |
| NCT04809220 | Completed | Phase 3 | A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes | April 13, 2021 | April 26, 2023 |
| NCT04880291 | Completed | Phase 1 | First-In-Human Study of GFB-024 in Healthy Overweight and Obese Participants, and Participants With Type 2 Diabetes | May 5, 2021 | February 8, 2022 |
| NCT04977739 | Completed | Research on the Application and Mechanism of New Biological Probes in Biomedicine | August 3, 2021 | July 25, 2022 | |
| NCT05210530 | Completed | Phase 1 | An Open-Label, FIH Study Evaluating the Safety and Tolerability of VCTX210A Combination Product in Subjects With T1D | January 24, 2022 | January 19, 2023 |
| NCT05269693 | Completed | N/A | A BHI to Increase Hope Level and Stress Level of Parents With a CMC | December 1, 2021 | February 1, 2023 |
| NCT05811689 | Completed | Trabecular Bone Score in Multiple Sclerosis | February 14, 2021 | February 15, 2023 | |
| NCT06069583 | Not yet recruiting | N/A | Implementation of Support in the Care of Adults Living With Type 1 Diabetes | January 5, 2024 | January 5, 2028 |
| NCT05910840 | Not yet recruiting | N/A | Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult Care | November 1, 2023 | June 1, 2027 |
| NCT04807166 | Not yet recruiting | Phase 2 | Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer | June 1, 2021 | December 1, 2024 |
| NCT06112340 | Recruiting | Phase 2/Phase 3 | A Phase 2b Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) | October 11, 2023 | June 2026 |
| NCT05272670 | Recruiting | N/A | Digital Foot Self-Management Program for Older-Diabetes | February 15, 2022 | August 31, 2022 |
| NCT04949282 | Recruiting | Spanish Series of Patients Treated With the Radionuclide Lutetium177 | May 10, 2021 | December 31, 2035 | |
| NCT04972955 | Recruiting | Predicting Dysglycemia in Individuals With Gestational Diabetes Immediately Postpartum Using Continuous Glucose Monitoring | July 4, 2023 | February 1, 2028 | |
| NCT05387070 | Recruiting | Phase 3 | PaTHway CHINA TRIAL: A Trial to Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism | July 28, 2021 | December 2025 |
| NCT04493632 | Recruiting | OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry. | April 12, 2022 | October 1, 2027 | |
| NCT05926115 | Recruiting | Phenotype and Epidemiology of the Polycystic Ovary Syndrome (PCOS) in Colombia (PEP - Colombia) Study. | March 4, 2023 | September 30, 2023 | |
| NCT05544266 | Recruiting | Rare and Atypical Diabetes Network | September 30, 2020 | September 2030 | |
| NCT05565248 | Recruiting | Phase 1/Phase 2 | An Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects With T1D | January 20, 2023 | August 2025 |
| NCT04460872 | Recruiting | Phase 2 | Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury | January 31, 2021 | June 30, 2025 |
| NCT04902378 | Recruiting | N/A | Closed-loop Insulin Delivery In Type 1 Diabetes Pregnancies (CIRCUIT) | June 15, 2021 | January 2026 |
| NCT05726461 | Recruiting | N/A | Efficacy and Safety of Android Artificial Pancreas System in Adult Patients With Type 1 Diabetes Mellitus in China | February 11, 2023 | September 30, 2024 |
| NCT05022667 | Recruiting | N/A | Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy | December 1, 2021 | August 2024 |
| NCT06226545 | Recruiting | Phase 2 | A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease | March 5, 2024 | September 2025 |
| NCT05263557 | Recruiting | N/A | Dissecting the IMpact of 11-OXygenated and Classic Androgens on Skeletal Muscle Insulin Sensitivity (DIMOXIS) | August 19, 2022 | December 2024 |
| NCT04371978 | Terminated | Phase 3 | Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19 | October 1, 2020 | May 4, 2021 |
| NCT00174291 | Terminated | Phase 3 | Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy | March 2002 | October 2011 |
| NCT00174187 | Terminated | Phase 3 | Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy | September 2000 | September 2011 |
| NCT02248701 | Terminated | Phase 2 | Testosterone Plus Finasteride Treatment After Spinal Cord Injury | April 27, 2017 | August 13, 2021 |
| NCT02027168 | Terminated | Effectiveness of Manual Physical Therapy to Improve Endocrine Levels in Women | February 2013 | January 2015 | |
| NCT04387448 | Terminated | Phase 2 | A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease | July 28, 2020 | November 1, 2022 |
| NCT00935766 | Terminated | Phase 3 | Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries | September 2009 | March 2012 |
| NCT03335254 | Terminated | Phase 1/Phase 2 | A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal Males | November 6, 2017 | May 3, 2018 |
| NCT04326374 | Unknown status | Phase 3 | Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Chinese Pediatric Growth Hormone Deficiency | December 30, 2019 | April 2022 |
| NCT04513197 | Unknown status | NEW ONSET ENDOCRINE DYSFUNCTION AFTER ACUTE PANCREATITIS | March 1, 2019 | August 30, 2020 | |
| NCT04556071 | Unknown status | Phase 2 | Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer | November 6, 2020 | October 1, 2022 |
| NCT04653779 | Unknown status | Phase 4 | A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and Efficacy/Safety of SUGAMET®XR Tablet 5/1000mg | December 2020 | July 2021 |
| NCT04700436 | Unknown status | Phase 4 | Efficacy and Safety of EzetimiBe/Rosuvastatin in Diabetic Dislipidemia With Hypertriglyceridaemia | January 3, 2020 | November 26, 2021 |
| NCT04836364 | Unknown status | Skincare Products and Environmental Health | January 14, 2019 | December 31, 2022 | |
| NCT05084079 | Unknown status | Phase 4 | Different Initial Insulin Dose Regimens on Time to Achieve Glycemic Targets and Treatment Safety in SIIT | November 2021 | October 2022 |
| NCT05090488 | Unknown status | N/A | Integration of Health Coaching and Diabetes Education in Type 2 Diabetes Mellitus Management at Primary Health Care | December 14, 2020 | June 2023 |
| NCT02203682 | Unknown status | Phase 2 | Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy | July 2014 | July 2022 |
| NCT02119572 | Unknown status | N/A | Impact of Peer Support on Diabetes in China | ||
| NCT01906281 | Unknown status | Influence of Adipocytokines in Osteoarthritis | July 2013 | December 2014 | |
| NCT01848171 | Unknown status | Phase 4 | Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism | July 2013 | July 2023 |
| NCT01831869 | Unknown status | Phase 4 | Effect of L-Thyroxine on Lipid Profiles and Atherosclerosis in Subclinical Hypothyroidism | April 2013 | April 2022 |
| NCT03736499 | Unknown status | Endocrine Changes in Adults Undergoing Cardiac Surgery | July 1, 2018 | May 30, 2022 | |
| NCT03682640 | Unknown status | Phase 2 | Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes | September 2018 | December 31, 2021 |
| NCT04039763 | Unknown status | N/A | RT-CGM in Young Adults at Risk of DKA | September 3, 2020 | June 30, 2022 |
| NCT04351945 | Unknown status | Endocrine Changes and Their Correction in Heart and Lung Transplant Recipients and Donors | May 20, 2020 | July 1, 2022 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D004700